A detailed understanding of the molecular mechanisms and the metabolic pathways engaged in the p53-dependent and -independent responses to cellular stress provides further insights on how to potentially target p53 clonal mutants that are known to contribute to the resistance of many cancers to conventional therapies. The gene discussed is TP53; the disease is cancer.